Kanseri y'ibihaha itari iy'uturemangingo duto (NSCLC)-02

Umurwayi w'umugabo w'imyaka 82 yagaragaye bwa mbere mu ntangiriro za Werurwe 2023 afite intege nke zigenda ziyongera, kubura ubushake bwo kurya, no kugabanya ibiro bigera kuri 5. Ubwo yakirwaga, hakozwe isuzuma ryimbitse. Isuzuma rya CT mu gituza ryagaragaje utunyangingo twinshi mu bihaha byombi, kinini kikaba cyaranganaga na cm 2.5. Utunyangingo twinshi mu gice cy'imbere cy'uruhande rw'iburyo n'utunyangingo twinshi mu gice cy'imbere cy'uruhande rw'ibumoso byombi byari bifite impande zitagaragara neza. Nyuma yo gupimwa no gupimwa mu gituza, hagaragajwe ko hari kanseri y'ibihaha itari nto (NSCLC), aho adenocarcinoma iri mu gice cy'imbere cy'uruhande rw'ibumoso n'igice cy'imbere cy'uruhande rw'iburyo.

Nyuma y’aho umurwayi yahawe uburyo bwo kuvura indwara za NK cell. Nyuma y’ukwezi kwa mbere avurwa, isuzuma ryakurikiyeho ryagaragaje ko nta mpinduka zigaragara mu bunini bw’uturemangingo tw’ibihaha, ariko ibimenyetso by’umurwayi muri rusange byari byarushijeho kuba byiza, aho intege nke zagabanutse kandi ubushake bwo kurya bugasubira buhoro buhoro. Nyuma y’ukwezi kwa kabiri avurwa, ikindi gipimo cya CT mu gituza cyagaragaje ko hari uburebure bugaragara neza ndetse n’ingano y’uturemangingo mu gice cy’imbere cy’agace k’iburyo ko hasi, ndetse n’igabanuka ry’uturemangingo mu gice cyo hejuru cy’agace k’ibumoso. Nyuma y’ukwezi kwa gatatu avurwa, CT mu gituza yagaragaje ko ingano y’uturemangingo mu bihaha byombi yagabanutse cyane, aho agace kanini katarengeje cm 1.5, hari ibisebe byo mu bihaha byinjizwa, kandi hari iterambere rikomeye mu buvuzi.

Muri make, ubuvuzi bwa NK cell immunotherapy bwagaragaje ko bufite akamaro kandi ko bwihanganirwa kuri uyu murwayi w’umugabo w’imyaka 82 ufite NSCLC, aho ibisebe by’ibihaha byagabanutse cyane kandi ubuzima bw’umurwayi bugakomeza kuba bwiza. Gahunda zo gukurikirana no gukomeza kuvura zizakomeza gukurikirana uko indwara igenda n’ingaruka zayo mu kuvura.